TAISHO PHARMACEUTICAL HOLDINGS
Taisho Pharmaceutical Holdings is a producer of generic drugs. They mainly manufacture and sell general cold medicines, allergy drugs, lipovitan series, pabron series, tempra, and more.
TAISHO PHARMACEUTICAL HOLDINGS
Industry:
Biotechnology Pharmaceutical
Founded:
1912-01-01
Status:
Active
Contact:
81-3-3985-2020
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SSL By Default Apache Pound Sterling Japanese Yen GlobalSign ARTERIA Networks Corporation Internet Initiative Japan
Similar Organizations
Eisai
Eisai is a human health care company that provides products and services to its patients and their families under any healthcare system.
Fangsheng Pharmaceutical
Hunan Fangsheng Pharmaceutical is a pharmaceutical company.
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Mitsubishi Tanabe Pharma
Mitsubishi Tanabe Pharma is pharmaceutical company.
Nanjing Pharmaceutical
Nanjing Pharmaceutical operates medicine supply chain businesses.
Takeda AS
Takeda AS is a science-driven biopharmaceutical company that develops medicines for patients.
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-12-19 | UPSA SAS | UPSA SAS acquired by Taisho Pharmaceutical Holdings | 1.6 B USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2024-04-04 | Biolinq | Taisho Pharmaceutical Holdings investment in Series D - Biolinq | 58 M USD |
| 2024-03-07 | VIE STYLE | Taisho Pharmaceutical Holdings investment in Series A - VIE STYLE | 305 M JPY |
| 2021-11-02 | Biolinq | Taisho Pharmaceutical Holdings investment in Series B - Biolinq | 100 M USD |
| 2021-08-19 | Moodify | Taisho Pharmaceutical Holdings investment in Series A - Moodify | 8 M USD |
| 2020-07-29 | Aiwell | Taisho Pharmaceutical Holdings investment in Series A - Aiwell | N/A |
| 2020-05-20 | Nanotis | Taisho Pharmaceutical Holdings investment in Seed Round - Nanotis | 60 M JPY |
| 2020-02-06 | Quantum Operation | Taisho Pharmaceutical Holdings investment in Corporate Round - Quantum Operation | 300 M JPY |
More informations about "Taisho Pharmaceutical Holdings"
Our Business - Taisho Pharmaceutical Holdings
At Taisho Pharmaceutical, many researchers are involved at every stage of the drug development process, from proposing new drug discovery ideas, conducting research and development, and filing applications for approval, and they are …See details»
Taisho Pharmaceutical - Wikipedia
Taisho was established in 1912 as Taisho Seiyakusho to produce over-the-counter drugs. In 1928 the company changed its name to Taisho Pharmaceutical Co., Ltd. and in 1955 moved into prescription drug R&D. It introduced its over-the-counter medications like cough suppressant in 1927, pain reliever in 1967 and an antiulcer agent in 1984. In 2019 Taisho bought French pharmaceutical manufacturer UPSA from Bristol Myers Squibb. See details»
Who We Are - Taisho Pharmaceutical Holdings
Learn about the management philosophy, corporate structure, and history of Taisho Pharmaceutical Holdings and the Taisho Pharmaceutical Group.See details»
Taisho Pharmaceutical Holdings Company Profile 2025: …
Apr 4, 2024 Taisho Pharmaceutical Holdings General Information Description. Taisho Pharmaceutical Holding Co Ltd is a specialty and generic drug manufacturing company. The company maintains two operational segments, …See details»
Taisho Pharmaceutical | Company Overview & News - Forbes
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. is a holding company engaged in the self-medication business and medical business. The Self-Medication segment is engaged in the …See details»
Taisho Pharmaceutical Holdings Company Profile - Craft
Apr 8, 2024 Taisho Pharmaceutical Holdings (大正製薬) is a company that focuses on the research, development, manufacture, and sale of over-the-counter (OTC) drugs and …See details»
Notice of Incorporation of Holding Company through Sole-Share …
Taisho Pharmaceutical Co., Ltd. (“Taisho”) hereby announces as set forth below that it has resolved in its board of directors meeting held today to incorporate “Taisho Pharmaceutical …See details»
TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. of TOSHIMA-KU, TOKYO. Get the latest …See details»
Japanese drugmaker Taisho eyes $5bn management …
Nov 25, 2023 TOKYO -- Taisho Pharmaceutical Holdings on Friday announced an offer by management to take the company private, looking to facilitate a pivot toward online and overseas sales of its mainstay over ...See details»
Taisho Pharmaceutical Holdings Co., Ltd. - Drug pipelines
Taisho Pharmaceutical Holdings Co. Ltd. is a company that manages its subsidiaries which produce and sell over-the-counter medications, food, and various other goods. The company …See details»
Corporate Governance - Taisho Pharmaceutical Holdings
Guided by this philosophy, Taisho Pharmaceutical Holdings Co., Ltd. (the “Company”) was established as a pure holding company to manage the Group as a whole. ... The Company is responsible for formulating Group management …See details»
Taisho says $5bn management buyout will rev up business
Dec 6, 2023 Japan’s Taisho Pharmaceutical looks like it could be heading into private ownership, thanks to a management buyout offer (MBO) that could value the company at …See details»
Taisho Pharmaceutical to Go Private in Japan’s Largest ... - JAKOTA
Jan 17, 2024 Taisho Pharmaceutical Holdings is poised for delisting following a successful tender offer led by Otemon, a Tokyo-based company owned by a member of Taisho’s …See details»
Taisho Pharmaceutical Holdings Co Ltd - Company Profile
Taisho Pharmaceutical Holdings Co Ltd (Taisho Pharmaceutical), a subsidiary of Otemon Co Ltd, develops, manufactures and markets self-medication drugs and prescription pharmaceuticals. …See details»
Taisho Pharmaceutical Holdings Co. Ltd - Disfold
Jan 1, 2024 Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is headquartered in Tokyo, Japan. Top 1-year algo backtest: +265.99% $10,000 in October 2023 …See details»
News（Organization） | Taisho Pharmaceutical Holdings
View news releases of Taisho Pharmaceutical Group in Organization.See details»
History - Taisho Pharmaceutical Holdings
Establishment of Taisho Pharmaceutical Holdings with the aim of achieving sustained growth both domestically and internationally. We continue to refine our group structure. ... The resulting …See details»
Taisho to Go Private through MBO in a Pivot to Longer-Term …
Nov 28, 2023 Taisho Pharmaceutical Holdings said on November 24 that the company will go private through the execution of a management buyout (MBO) as it looks towards longer-term …See details»
Taisho Pharmaceutical Holdings Co Ltd | ロイター
Feb 12, 2024 最新の国際 Taisho Pharmaceutical Holdings Co Ltd ニュースとビューは、世界最大の通信社の一つであるロイターが提供しています。See details»
Philosophy - Taisho Pharmaceutical Holdings
Learn how Taisho Pharmaceutical Holdings views its responsibility to society as a pharmaceutical company. To the text; To main menu; To header menu ... The Company's mission is to …See details»